Back to Search Start Over

Cytomegalovirus reactivation in immunocompetent mechanical ventilation patients: a prospective observational study.

Authors :
Zhang, Zhihui
Liu, Xuesong
Sang, Ling
Chen, Sibei
Wu, Zhan
Zhang, Jierong
Sun, Yining
Huang, Yongbo
Xu, Yonghao
He, Weiqun
Li, Yimin
Liu, Xiaoqing
Source :
BMC Infectious Diseases. 9/30/2021, Vol. 21 Issue 1, p1-10. 10p.
Publication Year :
2021

Abstract

<bold>Background: </bold>Cytomegalovirus (CMV) reactivation is associated with adverse prognoses of critically ill patients. However, the epidemiology and predictors of CMV reactivation in immunocompetent patients receiving mechanical ventilation (MV) are not clear. The aim of this study was to investigate the epidemiology and predictors of CMV reactivation in immunocompetent patients requiring MV.<bold>Methods: </bold>A single-center, prospective observational study (conducted from June 30, 2017 to July 01, 2018) with a follow-up of 90 days (September 29, 2018) that included 71 CMV-seropositive immunocompetent patients with MV at a 37-bed university hospital general intensive care unit (ICU) in China. Routine detection of CMV DNAemia was performed once a week for 28 days (Days 1, 7, 14, 21, and 28). CMV serology, laboratory findings, and clinical data were obtained during hospitalization.<bold>Results: </bold>Among 71 patients, 13 (18.3%) showed CMV reactivation within 28 days in the ICU. The median time to reactivation was 7 days. CMV reactivation was related to various factors, including body mass index (BMI), sepsis, N-terminal pro-b-type natriuretic peptide (NT-proBNP), blood urea nitrogen (BUN), and hemoglobin (Hb) levels (P < 0.05). In the multivariate regression model, BMI, Hb level, and sepsis were independently associated with CMV reactivation patients (P < 0.05). Moreover, the area under the receiver operating characteristic (AUROC) of BMI, Hb, and BMI combined with Hb was 0.69, 0.70, and 0.76, respectively. The duration of MV, hospitalization expense, length of ICU stay, and 90 day all-cause mortality rate in patients with CMV reactivation was significantly higher than in those without CMV reactivation (P < 0.05).<bold>Conclusions: </bold>Among immunocompetent patients with MV, the incidence of CMV reactivation was 18.3%. CMV reactivation was associated with several adverse prognoses. BMI, Hb, and sepsis were independent risk factors for CMV reactivation. BMI and Hb may predict CMV reactivation. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14712334
Volume :
21
Issue :
1
Database :
Academic Search Index
Journal :
BMC Infectious Diseases
Publication Type :
Academic Journal
Accession number :
152743575
Full Text :
https://doi.org/10.1186/s12879-021-06698-0